CRP and COVID-19: Due to there being no precise and specific antiviral medicine for this emerging illness, MSCs were applied in several critically ill COVID-19 patients, contributing to the decline of plasma C reactive protein (CRP), aspartic aminotransferase, creatine kinase activity, and myoglobin.